$1.67
0.000.00%
Pre-Market: 7:51 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Protalix BioTherapeutics in recent months.
Browse guidance and forecast on all stocks.